The characterization of the immune TME of cancers was an early application of ML/DL methods to pathology specimens; however, computational pathology is now enabling the accurate quantification of TILs and PD‐L1 in tumor and immune cells that goes beyond that attainable by visual quantification. This evidence concerns the gene CD274 and neoplasm.